Search Results for "Alnylam"

Alnylam is committed to providing the healthcare community with balanced, accurate, and high-quality information about our science, therapeutic areas, and products.

More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.

For more information about our FDA-approved therapies, please see the Full Prescribing Information:

Givosiran: Use in Patients Without an Identified Porphyria-Related Mutation

Standard response letter on the use of givosiran in patients with AHP without an identified porphyria-related genetic mutation.

Long-term Effects of Patisiran on Survival and Cardiac Parameters in Patients with Transthyretin-mediated Cardiac Amyloidosis: Post Hoc Analysis of APOLLO-B and Cardiac Subpopulation of APOLLO OLE

For further information regarding your request, please connect with us by reaching out to your local Medical Science Liaison or contacting our Medical Information team.